Beacon Therapeutics logo

Beacon Therapeutics

Transforming Vision, Transforming Lives

95 employees · est. 2023 · London, United Kingdom

VS
Ray Therapeutics, Inc. logo

Ray Therapeutics, Inc.

Optogenetic Gene Therapy Company

46 employees · est. 2021 · Berkeley, United States

Ray Therapeutics, Inc. is the older company (2023 vs 2021); Beacon Therapeutics is the larger of the two.

Side-by-Side Comparison

Beacon Therapeutics Ray Therapeutics, Inc.
Founded
2023 2021 older
Headquarters
London, United Kingdom Berkeley, United States
Employees
95 larger 46
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series C Series B
Total Funding
$341.00M $235.00M
Funding Rounds
4 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Ophthalmic Gene Therapy, Retinal Diseases, X-linked Retinitis Pigmentosa, AMD (age-related Macular Degeneration), Cone-rod Dystrophy, Gene Therapy Program, RPGR Gene, Clinical Trials, Target Generation Technology, Syncona, Oxford Science Enterprises, Inherited Retinal Diseases, Vision Restoration, Blindness Optogenetic Gene Therapy, Vision Restoration, Retinal Blindness, Age-related Macular Degeneration, Retinitis Pigmentosa, ChRown Optogenetic Protein, AAV Gene Therapy, Precision Therapy, Clinical Trials, Gene Therapy Manufacturer, Visual Acuity, Contrast Sensitivity, Visual Field, Preclinical Stage
Website
beacontx.com raytherapeutics.com
Beacon Therapeutics logo

About Beacon Therapeutics

Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases leading to blindness. The company's scientific foundation encompasses a late-stage development candidate...

Ray Therapeutics, Inc. logo

About Ray Therapeutics, Inc.

Ray Therapeutics, Inc. (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Their studies have shown for the fir...

We will tell you when either one moves

BounceWatch watches Beacon Therapeutics and Ray Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Beacon Therapeutics and Ray Therapeutics, Inc. — by email.

Frequently Asked Questions

Beacon Therapeutics — Transforming Vision, Transforming Lives. Ray Therapeutics, Inc. — Optogenetic Gene Therapy Company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Beacon Therapeutics has raised $341.00M while Ray Therapeutics, Inc. has raised $235.00M.
Beacon Therapeutics and Ray Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Beacon Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Beacon Therapeutics on 9 Jun 2026, and Ray Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes